Preoperative ROS1-TKI Therapy for ROS1 Fusion-Positive Locally Advanced Lung Adenocarcinoma

by | Jul 15, 2026 | Clinical Trials | 0 comments

​ Conditions: ROS1 Fusion-Positive Lung Adenocarcinoma

Interventions: Drug: ROS1-TKI Therapy

Sponsors: Peking University Cancer Hospital & Institute

Completed Conditions: ROS1 Fusion-Positive Lung Adenocarcinoma
Interventions: Drug: ROS1-TKI Therapy
Sponsors: Peking University Cancer Hospital & Institute
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *